Scientists test new drug formulation in early safety study
NCT ID NCT06502561
Summary
This early study aims to understand how the body absorbs a new granule form of the drug Aramchol compared to its existing tablet form. Sixteen healthy volunteers will take single doses of each form on different days to measure drug levels in their blood. The goal is to see if the new granule form behaves similarly to the tablet, which is a necessary first step before testing it in patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Diagnostic & Consultative Centre 'Ascendent' Ltd.
Sofia, 1202, Bulgaria
Conditions
Explore the condition pages connected to this study.